Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs Propofol for Ambulatory Upper Airway Surgery
NCT06507202Phase 4Recruiting
- Sponsor
- Chung-Ang University Gwangmyeong Hospital
- Start
- Jan 2024
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of remimazolam in Laryngeal disease, oral cavity diseases, Nose diseases, sponsored by Chung-Ang University Gwangmyeong Hospital. Started Jan 2024; status: recruiting.
02
Drugs
remimazolam
03
Conditions
Laryngeal diseaseoral cavity diseasesNose diseases
Beyond the preview
Go deeper on NCT06507202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06507202.